Published in Hepatitis Weekly, September 29th, 2008
"Forty-two patients chronically infected with HCV (for genotype 1, [Formula: see text]; for genotype 6, [Formula: see text]) were treated with pegylated interferon alpha-2a ([Formula: see text]) or alpha-2b...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.